Nicox SA, an international ophthalmology company, announced that the last patient has completed the Denali Phase 3 trial, evaluating the efficacy and safety of NCX
Topline results and full data analysis expected in Q4 2025 BioStem Technologies, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived
In an investigator-sponsored study of OM336, two patients with relapsed/refractory autoimmune hemolytic anemia showed rapid and sustained remissions out to month six, without other immunosuppressive
New case study shows 64% of participants represent diverse populations While clinical trials have historically struggled with participation among underrepresented populations, EmVenio Research breaks the
Collaboration will support trial planning for Trace Neuroscience’s upcoming Phase 1/2 clinical trial in ALS Unlearn, a leader in AI-powered solutions for clinical trials, announced
Memorial Healthcare System is one of only four healthcare centers in the nation to have participated in a clinical trial for the Pleural Dynamics ACES System,
Program supports the Medidata Patient, Data, and Study Experiences, boosting site engagement, eliminating clinical trial inefficiencies, and increasing tech compliance Medidata, a Dassault Systèmes brand and
Health Canada’s approval enables 4Moving Biotech to initiate the INFLAM MOTION Phase 2a clinical trial 4Moving Biotech , a spin-off of 4P-Pharma dedicated to developing
Medrio, a global leader in clinical trial technology, announced enhancements to its randomization and trial supply management (RTSM) solution. This latest release delivers faster implementation, greater
Avant Technologies, Inc. and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI),
Fuel up with free Health Tech Insights
